PET in oncology: will it replace the other modalities?

[1]  R L Wahl,et al.  Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. , 1993, Radiology.

[2]  J. Roodenburg,et al.  Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  L. Mortelmans,et al.  Clinical value of whole‐body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer , 1994, The British journal of surgery.

[4]  G. Hortobagyi,et al.  Positron emission tomography with fluorine‐18‐deoxyglucose in the detection and staging of breast cancer , 1993, Cancer.

[5]  G. van Kaick,et al.  PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  J. Itami,et al.  Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  B. Karlan,et al.  Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma. , 1993, Gynecologic oncology.

[8]  M. Kaminski,et al.  Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. , 1994, Radiology.

[9]  S. Minoshima,et al.  The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  J. Keyes.  SUV: standard uptake or silly useless value? , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  M. Goldberg,et al.  Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1995, Radiology.

[12]  R. Lufkin,et al.  Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. , 1993, Radiology.

[13]  M E Phelps,et al.  The application of positron emission tomographic imaging with fluorodeoxyglucose to the evaluation of breast disease. , 1992, Annals of surgery.

[14]  P Schmidlin,et al.  Recurrence of colorectal tumors: PET evaluation. , 1989, Radiology.

[15]  David J. Yang,et al.  Detecting recurrent or residual lung cancer with FDG-PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  G Jakse,et al.  Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. , 1996, The Journal of urology.

[17]  P. M. Falk,et al.  Pre-operative staging of colorectal carcinoma using positron emission tomography. , 1993, The Nebraska medical journal.

[18]  Michael E. Phelps,et al.  Cancer Detection with Whole‐Body PET Using 2‐[18F]Fluoro‐2-Deoxy‐D-Glucose , 1993, Journal of computer assisted tomography.

[19]  R L Wahl,et al.  Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1991, Radiology.

[20]  R. Coleman,et al.  Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. , 1993, Radiology.

[21]  Barry H. Smith,et al.  Glycolytic Rate and Histologic Grade of Human Cerebral Gliomas: A Study with [18F]Fluorodeoxyglucose and Positron Emission Tomography , 1983 .

[22]  M E Phelps,et al.  Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  M E Phelps,et al.  Whole-Body Positron Emission Tomography and Fluorodeoxyglucose , 2006 .

[24]  Y. Yonekura,et al.  Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  D. Slosman,et al.  Satellite PET and lung cancer: a prospective study in surgical patients , 1993, Nuclear medicine communications.

[26]  A. Alavi,et al.  Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  J L Sunshine,et al.  Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. , 1993, Radiology.

[28]  R A Brooks,et al.  Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography , 1982, Neurology.

[29]  H. Friess,et al.  2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation. , 1995, Radiology.

[30]  L. Adler,et al.  Positron emission tomography of thyroid masses. , 1993, Thyroid : official journal of the American Thyroid Association.

[31]  V J Lowe,et al.  Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). , 1995, The Journal of thoracic and cardiovascular surgery.

[32]  T Jones,et al.  Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.

[33]  C. Kufta,et al.  Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. , 1987, AJR. American journal of roentgenology.

[34]  G van Kaick,et al.  Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  M E Phelps,et al.  Whole-body positron emission tomography: Part I. Methods and performance characteristics. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  R Paul,et al.  Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  M. Phelps,et al.  Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[38]  H. Kreisman,et al.  The Solitary Pulmonary Nodule , 1985 .

[39]  R. Wahl,et al.  Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy. , 1993, The Journal of clinical endocrinology and metabolism.

[40]  G. Chiro.  Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. , 1987 .

[41]  L. Adler,et al.  Determination of malignancy of thyroid nodules with positron emission tomography. , 1993, Surgery.

[42]  N. Gupta,et al.  Experience with positron emission tomography (PET) scans in patients with ovarian cancer. , 1994, Gynecologic oncology.

[43]  M. Fulham,et al.  The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. , 1996, Archives of surgery.

[44]  R A Hawkins,et al.  Whole body skeletal imaging with [18F]fluoride ion and PET. , 1993, Journal of computer assisted tomography.

[45]  R. Wahl,et al.  Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[46]  J. Reed,et al.  Mediastinal staging of non-small-cell lung cancer with positron emission tomography. , 1995, American journal of respiratory and critical care medicine.

[47]  L. Griffeth,et al.  FDG-PET evaluation of indeterminate pancreatic masses. , 1996, Journal of computer assisted tomography.

[48]  R. Wahl,et al.  Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose. , 1991, The New England journal of medicine.

[49]  R. Wahl,et al.  Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. , 1996, Radiology.

[50]  W N Hanafee,et al.  Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation. , 1993, Radiology.

[51]  R L Wahl,et al.  Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  G. di Chiro,et al.  Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study. , 1987, Radiology.

[53]  Michael E. Phelps,et al.  Positron Emission Tomography of the Brain , 1983, Springer Berlin Heidelberg.

[54]  Y. Nishimura,et al.  Monitoring liver tumor therapy with [18F]FDG positron emission tomography. , 1990, Journal of computer assisted tomography.

[55]  L. Strauss,et al.  The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. , 1993, The Journal of otolaryngology.

[56]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[57]  S. Larson,et al.  Metabolic imaging of human extremity musculoskeletal tumors by PET. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[58]  S S Gambhir,et al.  Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[59]  R. Wahl,et al.  Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. , 1994, Radiology.

[60]  J S Fowler,et al.  Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma. , 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[61]  R Iwata,et al.  Differential diagnosis of lung tumor with positron emission tomography: a prospective study. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  J H Thrall,et al.  Fluorodeoxyglucose PET of abdominal and pelvic neoplasms: potential role in oncologic imaging. , 1993, Radiographics : a review publication of the Radiological Society of North America, Inc.

[63]  G. Marchal,et al.  Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[64]  M P Frick,et al.  Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. , 1993, Chest.

[65]  R P Williams,et al.  Noninvasive grading of musculoskeletal tumors using PET. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  R. Wahl,et al.  Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. , 1996, Radiology.

[67]  J. Sunderland,et al.  Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. , 1992, Radiology.

[68]  K. Hubner,et al.  Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG). , 1993, Gynecologic oncology.

[69]  E. Gunel,et al.  Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[70]  D. Delbeke,et al.  Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. , 1996, Chest.

[71]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[72]  T. Hickish,et al.  Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  K. Någren,et al.  Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[74]  G van Kaick,et al.  Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  S. Cummings,et al.  Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. , 1986, The American review of respiratory disease.

[76]  S. Hauptmann,et al.  F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer. , 1994, Radiology.

[77]  Y. Yonekura,et al.  Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US. , 1995, Radiology.

[78]  E Abemayor,et al.  Positron emission tomography: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy , 1992, The Laryngoscope.

[79]  T. Fukumura,et al.  Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[80]  N. Gupta,et al.  PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. , 1995, Chest.

[81]  M. Phelps,et al.  Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[82]  T. McLoud,et al.  Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.